MedTrace Logo

Thulium Laser En-bloc Resection of Primary Non-muscle Invasive Bladder Cancer

NCT06818799 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2025-02-12

No results posted yet for this study

Summary

The goal of this clinical trial is to know if thulium laser works to treat non-muscle invasive bladder cancer "NMIBC" efficiently in comparison to classical trans-urethral resection "TURBT". It will also learn about the safety of this technique. The main questions it aims to answer are:

Does thulium laser lower the incidence of recurrence to participants with non- muscle invasive bladder cancer? What complications do participants have when using this technique? Investigators will compare thulium laser en-bloc resection to a classical trans-urethral en-bloc resection of bladder tumor

Participants will:

Do thulium laser en-bloc resection or trans-urethral en-bloc resection And will be classified to risk group according to European association of urology guidelines and followed up accordingly.

Conditions

  • Bladder Transitional Cell Carcinoma

Interventions

PROCEDURE

Thulium laser en-bloc resection of bladder mass

En-bloc laser technique

PROCEDURE

Trans-urethral en-bloc resection of bladder mass

En-bloc technique

Sponsors & Collaborators

  • Ain Shams University

    collaborator OTHER

  • Maadi Military Hospital

    collaborator OTHER_GOV

  • Helwan University

    lead OTHER

Principal Investigators

  • Tarek AM Salem, MD · Tarek Abdel magied Salem

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-08-13
Primary Completion
2024-11-15
Completion
2024-12-10

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06818799 on ClinicalTrials.gov